These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Risk of leukemia associated with chemotherapy. Griffiths WA Br Med J (Clin Res Ed); 1985 Feb; 290(6467):555. PubMed ID: 3918668 [No Abstract] [Full Text] [Related]
12. Razoxane: a review of 6 years' therapy in psoriasis. Horton JJ; Wells RS Br J Dermatol; 1983 Dec; 109(6):669-73. PubMed ID: 6652043 [TBL] [Abstract][Full Text] [Related]
13. A nail psoriasis severity index. Baran RL Br J Dermatol; 2004 Mar; 150(3):568-9. PubMed ID: 15030343 [TBL] [Abstract][Full Text] [Related]
14. Razoxane in the treatment of psoriasis. Hill GW; Roach M Br J Dermatol; 1980 Nov; 103(5):583-5. PubMed ID: 7437323 [No Abstract] [Full Text] [Related]
15. Distinct patterns of chromonychia, Beau's lines, and melanoderma seen with vincristine, adriamycin, dexamethasone therapy for multiple myeloma. Dasanu CA; Vaillant JG; Alexandrescu DT Dermatol Online J; 2006 Oct; 12(6):10. PubMed ID: 17083890 [TBL] [Abstract][Full Text] [Related]
16. Razoxane (ICRF 159) in the treatment of psoriasis. Atherton DJ; Wells RS; Laurent MR; Williams YF Br J Dermatol; 1980 Mar; 102(3):307-17. PubMed ID: 7370178 [TBL] [Abstract][Full Text] [Related]
17. Unilateral Beau's lines associated with a fractured olecranon. Avery H; Cooper HL; Karim A Australas J Dermatol; 2010 May; 51(2):145-6. PubMed ID: 20546225 [TBL] [Abstract][Full Text] [Related]
18. Images in clinical medicine. Multiple Beau's lines. Park J; Li K N Engl J Med; 2010 May; 362(20):e63. PubMed ID: 20484394 [No Abstract] [Full Text] [Related]